Lidds AB Logo

Lidds AB

LIDDS

Overview

Corporate Details

ISIN(s):
SE0001958612
LEI:
549300YYW8B918K7UN72
Country:
Sweden
Address:
Box 12040, 112 40 Stockholm
Sector:
Health Care
Industry:
Biotechnology

Description

Lidds AB develops innovative drug delivery technologies for cancer treatment.

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Insider Transactions

Date Insider Name Position Type Shares Value
2023-02-14 Anders Månsson Other Buy 100,000 140,000.00 SEK
2023-02-10 Matthew Lindon Other Buy 71,428 99,999.20 SEK
2023-02-09 Daniel Lifveredson Other Other 150,000 210,000.00 SEK
2022-12-16 Daniel Lifveredson Other Sell 435,254 826,982.60 SEK
2022-12-16 Daniel Lifveredson Other Buy 435,254 826,982.60 SEK
2022-06-02 Galba Holding AB Other Buy 750,000 4,500,000.00 SEK
2022-03-08 Jan Törnell Other Buy 5,000 32,500.00 SEK
2021-06-30 Nina Herne Other Other 100,000 116,000.00 SEK
2021-06-03 Daniel Lifveredson Other Buy 435,254 4,483,116.20 SEK
2021-05-31 Maria Forss Other Buy 2,300 29,992.00 SEK

Peer Companies

Company Country Ticker View
GenSight Biologics S.A. Logo GenSight Biologics S.A. France SIGHT
Gentian Diagnostics ASA Logo Gentian Diagnostics ASA Norway GENT
Genus PLC Logo Genus PLC United Kingdom GNS
Grace Breeding Ltd. Logo Grace Breeding Ltd. Israel GRAC
Group 107 Ltd. Logo Group 107 Ltd. Israel G107
Guard Therapeutics International AB Logo Guard Therapeutics International AB Sweden GUARD
Gubra A/S Logo Gubra A/S Denmark GUBRA
Hadasit Bio Holding Ltd. Logo Hadasit Bio Holding Ltd. Israel HDST-M
Hansa Biopharma Logo Hansa Biopharma Sweden HNSA
HEMOGENYX PHARMACEUTICALS PLC Logo HEMOGENYX PHARMACEUTICALS PLC United Kingdom HEMO